Pharmaceutical Pollution Turns Djibouti's Gulf of Tadjourah Into Chemical Cocktail, Study Warns
Guest Contributor
Contributor
A recent study published in Marine Pollution Bulletin has detected dangerous concentrations of pharmaceutical and personal care compounds in coastal waters along Djibouti's Gulf of Tadjourah, including ibuprofen at levels hundreds of times higher than those considered safe for aquatic organisms at sites where urban and hospital wastewater are discharged directly into the sea. The findings, led by environmental chemist Abdillahi Elmi Adaneh of the regional Observatory for Research on the Environment and Climate, represent one of the few pharmaceutical pollution studies carried out in East Africa and position Djibouti as a cautionary example for low- and middle-income countries with limited wastewater treatment capacity.
Scale of Contamination and Key Compounds Detected
Researchers identified 15 pharmaceutical and personal care compounds across multiple sampling sites along the Gulf of Tadjourah, including ibuprofen, caffeine, carbamazepine, and levofloxacin, an antibiotic used in tuberculosis treatment. Caffeine was detected at every sampling site and is widely used in environmental science as an indicator of domestic wastewater contamination, confirming the direct pathway from urban discharge to coastal water. Ibuprofen emerged as the compound of greatest ecological concern, with concentrations at hospital and urban wastewater discharge sites reaching hundreds of times above the thresholds considered safe for aquatic organisms. Adaneh has noted that these substances are commonly perceived as ordinary and low-risk, yet their concentrations and combined effects in the coastal environment present a significantly more serious picture than their individual everyday familiarity suggests. The antiepileptic drug carbamazepine is particularly concerning because it is highly persistent in aquatic environments and does not degrade readily under natural conditions.
Ecological Risks to a Marine Biodiversity Hotspot
The Gulf of Tadjourah is an important marine biodiversity hotspot hosting coral reefs, mangroves, and fish nurseries, making it one of the most ecologically sensitive areas along the East African coast. Djibouti City, home to more than 70 percent of the country's population, borders the gulf and is the primary source of the untreated wastewater flows identified in the study. Ibuprofen and other non-steroidal anti-inflammatory drugs can disrupt reproduction, growth, enzymatic activity, and physiological responses in marine organisms, with invertebrates, fish, and algae identified as particularly sensitive groups. The cumulative or cocktail effect of multiple pharmaceutical compounds present simultaneously is considered even more ecologically damaging than the sum of individual substance impacts, since interactions between compounds can amplify toxicity in ways that single-substance risk assessments fail to capture. The proximity of the contamination to coral reef and mangrove habitats means that the ecological risk extends beyond pelagic organisms to the foundational habitats on which broader marine biodiversity in the region depends.
Wastewater Infrastructure as the Critical Gap
The study identifies untreated wastewater discharge as the primary driver of pharmaceutical contamination in the Gulf of Tadjourah, and data from the United Nations indicates that only 11 percent of domestic wastewater is treated in Djibouti. The remaining 89 percent is discharged into the environment, carrying the full spectrum of pharmaceutical residues, pathogens, heavy metals, and nutrients consumed and excreted by the urban population. The contrast with outcomes in cities that have invested in wastewater treatment is instructive. In Marseille, France, the introduction of a wastewater treatment plant in 1987 enabled the recovery of sensitive species including neptune grass and salema porgy in coastal waters that had previously been severely degraded. The Marseille example demonstrates that pharmaceutical and domestic wastewater pollution is reversible given adequate infrastructure investment, and provides a practical reference for the policy case in Djibouti and similar contexts. Adaneh has framed the situation as a problem that makes Djibouti a cautionary tale for many low- and middle-income countries facing similar infrastructure deficits.
Global Context and Broader Implications
Pharmaceutical pollution of marine environments is a growing global concern. A 2022 global study found evidence of pharmaceutical contamination in remote locations including Antarctica, demonstrating that the problem is not confined to densely populated or industrialised coastlines but extends to effectively pristine environments through atmospheric transport, ocean circulation, and the cumulative effect of widespread pharmaceutical use. The Djibouti study contributes to a still-limited body of evidence from East Africa and reinforces the case for expanding pharmaceutical pollution monitoring to low- and middle-income coastal countries where urbanisation is rapid, pharmaceutical consumption is rising, and wastewater treatment infrastructure has not kept pace. For the ocean economy in these regions, pharmaceutical contamination of coastal waters poses direct risks to fisheries, aquaculture, and marine tourism that compound the existing pressures from overfishing, climate change, and physical habitat degradation.
Guest Contributor
Contributor
This article was contributed by an external writer affiliated with our publication.
